Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ekso Bionics Holdings Inc (EKSO)

Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,675
  • Shares Outstanding, K 17,903
  • Annual Sales, $ 18,280 K
  • Annual Income, $ -15,200 K
  • 60-Month Beta 1.65
  • Price/Sales 1.42
  • Price/Cash Flow N/A
  • Price/Book 1.73
Trade EKSO with:

Options Overview Details

View History
  • Implied Volatility 243.63% ( +66.89%)
  • Historical Volatility 99.61%
  • IV Percentile 72%
  • IV Rank 25.27%
  • IV High 880.76% on 08/17/23
  • IV Low 28.16% on 11/13/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 47
  • Volume Avg (30-Day) 86
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 1,014
  • Open Int (30-Day) 1,505

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.16
  • Number of Estimates 1
  • High Estimate -0.16
  • Low Estimate -0.16
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +51.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3200 +7.58%
on 03/18/24
2.1563 -34.15%
on 03/04/24
-0.5500 (-27.92%)
since 02/27/24
3-Month
1.3200 +7.58%
on 03/18/24
3.1285 -54.61%
on 01/02/24
-0.2500 (-14.97%)
since 12/27/23
52-Week
0.6200 +129.03%
on 09/08/23
3.1285 -54.61%
on 01/02/24
-0.1200 (-7.79%)
since 03/27/23

Most Recent Stories

More News
Ekso Bionics: Q4 Earnings Snapshot

Ekso Bionics: Q4 Earnings Snapshot

EKSO : 1.4200 (-4.70%)
Ekso Bionics: Q3 Earnings Snapshot

Ekso Bionics: Q3 Earnings Snapshot

EKSO : 1.4200 (-4.70%)
Ekso Bionics: Q2 Earnings Snapshot

Ekso Bionics: Q2 Earnings Snapshot

EKSO : 1.4200 (-4.70%)
Ekso Bionics: Q1 Earnings Snapshot

Ekso Bionics: Q1 Earnings Snapshot

EKSO : 1.4200 (-4.70%)
Ekso Bionics: Q4 Earnings Snapshot

Ekso Bionics: Q4 Earnings Snapshot

EKSO : 1.4200 (-4.70%)
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.4200 (-4.70%)
SWAV : 322.61 (+2.07%)
Ekso Bionics: Q3 Earnings Snapshot

Ekso Bionics: Q3 Earnings Snapshot

EKSO : 1.4200 (-4.70%)
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates

Integra (IART) delivered earnings and revenue surprises of 19.44% and 1.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

IART : 34.83 (+3.20%)
EKSO : 1.4200 (-4.70%)
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 1.4200 (-4.70%)
PEN : 226.38 (+2.49%)
Ekso Bionics Reports Second Quarter 2022 Results

RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton...

EKSO : 1.4200 (-4.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western...

See More

Key Turning Points

3rd Resistance Point 1.5633
2nd Resistance Point 1.5267
1st Resistance Point 1.4733
Last Price 1.4200
1st Support Level 1.3833
2nd Support Level 1.3467
3rd Support Level 1.2933

See More

52-Week High 3.1285
Fibonacci 61.8% 2.1703
Fibonacci 50% 1.8742
Fibonacci 38.2% 1.5782
Last Price 1.4200
52-Week Low 0.6200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar